You may also like
Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019
Argatroban, with or without aspirin, is an effective anticoagulation strategy for patients who require venovenous extracorporeal membrane oxygenation support secondary to coronavirus disease 2019. In comparison with heparin, this anticoagulation strategy was not associated with a significant difference in bleeding or thrombotic complications, and was associated with a significantly decreased time to therapeutic anticoagulation goal, likely as a result of high rates of heparin resistance observed in this patient population.
1 min read
AbioCor Patient Dies During Implantation Surgery
A sixth patient to be implanted with an AbioCor artificial heart died during surgery Tuesday at St. Luke’s Episcopal Hospital in Houston, […]
2 min read
A Review of Emergency Cardiopulmonary Bypass for Severe Poisoning by Cardiotoxic Drugs
This article will review current ECPB techniques and explore its growing role in the treatment of severely hemodynamically compromised poisoned patients.
1 min read